Kristen Harrington-Smith
Corporate Officer/Principal presso ADC THERAPEUTICS SA
Patrimonio netto: - $ in data 31/05/2024
Profilo
Kristen Harrington-Smith is currently working at ADC Therapeutics SA. She previously worked at eFFECTOR Therapeutics, Inc. as an Independent Director from 2022 to 2024.
Before that, she was the US Commercial Head-Hematology at Novartis Pharmaceuticals from 2020 to 2021.
She also worked at ImmunoGen, Inc. from 2021 to 2022.
Ms. Harrington-Smith completed her undergraduate degree at Williams College and holds an MBA from Kenan-Flagler Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 13/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Kristen Harrington-Smith
| Società | Posizione | Inizio |
|---|---|---|
| ADC THERAPEUTICS SA | Corporate Officer/Principal | 17/11/2022 |
Precedenti posizioni note di Kristen Harrington-Smith
| Società | Posizione | Fine |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 21/06/2024 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 16/11/2022 |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 01/11/2021 |
Formazione di Kristen Harrington-Smith
| Williams College | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Aziende private | 2 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
- Borsa valori
- Insiders
- Kristen Harrington-Smith
